Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y002374 | — |
No additional AE reported; PROQUAD was administered to a 22-year-old consumer; This spontaneous report was received from a/an Other health professional and refers to a 22-year-old patient of unknown gender. The patient's previous adverse drug reaction history and family adverse drug reactions were not reported. The patient's concomitant therapies, medical histories and drug allergies were not applicable. On 07-Jul-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y002374, expiration date: 14-Jul-2025) (strength, formulation route of administration, vaccination scheme frequency, anatomical location, and dose were not reported) for Prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (Product administered to patient of inappropriate age). No additional AE reported. No PQC reported. No additional information provided.
Diluent Mrk